Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Ipilimumab × Tumor-Agnostic × Clear all

Phase

Phase 2 8 Phase 1 7 Phase 1/2 6 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Dermatologic 2 Tumor-Agnostic 1 Thoracic 1

Conditions

Interventions

Drug Therapy 5 Docetaxel 3 icotinib 2 Pemetrexed 2 Misoprostol 2 Genes, p53 2 Gemcitabine 2 Dexamethasone 2 Carboplatin 2 Bevacizumab 2 Aspirin 2 pinaverium 1 pembrolizumab 1 pazopanib 1 netupitant, palosentron drug combination 1 nedaplatin 1 lorlatinib 1 durvalumab 1 ceritinib 1 atezolizumab 1 Zoledronic Acid 1 Water 1 Vitamin E 1 Vincristine 1 Vemurafenib 1 Triamcinolone 1 Trastuzumab 1 Thalidomide 1 Surgical Procedures, Operative 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06031233 2025-05-21

MINUTE

Isala

Phase 4 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡